| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.023 | 0.6 |